Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Cantor Fitzgerald Upgrades Ironwood Pharmaceuticals (IRWD) to Hold
-
Cantor Fitzgerald Starts Synergy Pharmaceuticals (SGYP) at Buy
-
Cantor Fitzgerald Reiterates a 'Sell' on Ironwood Pharmaceuticals (IRWD); Shares Still Overvalued
-
Cantor Fitzgerald Reiterates a 'Sell' on Ironwood Pharmaceuticals (IRWD); Expect Sell-Off Even in Best-Case Scenario
-
Cantor Fitzgerald Downgrades Ironwood Pharmaceuticals (IRWD) to Sell; Recommend Taking Profits
-
Cantor Fitzgerald Downgrades Ironwood Pharmaceuticals (IRWD) to Sell
-
Cantor Fitzgerald Starts Ironwood Pharmaceuticals (IRWD) at Hold; The Waiting Is The Hardest Part

